09 April 2026
09 April 2026
AI Airlock is jointly run by the MHRA, DHSC, NHS AI Team, and Team AB, the consortium of UK Approved Bodies.
The Phase I segment will enrol up to 30 patients with recurrent and progressive GBM or other high-grade gliomas.
The fund’s resources allow it to invest up to €150m, helping businesses advance clinical development.
Varipulse Pro introduces a new pulse sequence with lower temperature and five times faster ablation.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
